Abstract
Rollouts of COVID-19 vaccines in the USA were opportunities to redress disparities that surfaced during the pandemic. Initial eligibility criteria, however, neglected geographic, racial/ethnic, and socioeconomic considerations. Marginalized populations may have faced barriers to then-scarce vaccines, reinforcing disparities. Inequalities may have subsided as eligibility expanded. Using spatial modeling, we investigate how strongly local vaccination levels were associated with socioeconomic and racial/ethnic composition as authorities first extended vaccine eligibility to all adults. We harmonize administrative, demographic, and geospatial data across postal codes in eight large US cities over 3 weeks in Spring 2021. We find that, although vaccines were free regardless of health insurance coverage, local vaccination levels in March and April were negatively associated with poverty, enrollment in means-tested public health insurance (e.g., Medicaid), and the uninsured population. By April, vaccination levels in Black and Hispanic communities were only beginning to reach those of Asian and White communities in March. Increases in vaccination were smaller in socioeconomically disadvantaged Black and Hispanic communities than in more affluent, Asian, and White communities. Our findings suggest vaccine rollouts contributed to cumulative disadvantage. Populations that were left most vulnerable to COVID-19 benefited least from early expansions in vaccine availability in large US cities.
Highlights
IntroductionBackground: COVID‐19 Vaccine Rollouts in the USA
COVID‐19 Vaccine Rollouts in the USAIn early 2021, state and local authorities in the USA vaccinated millions of people weekly against coronavirus disease 2019 (COVID-19).[1]
Vaccines were free regardless of health insurance coverage, local vaccination levels in March and April were negatively associated with poverty, enrollment in means-tested public health insurance (e.g., Medicaid), and the uninsured population
Summary
Background: COVID‐19 Vaccine Rollouts in the USA. In early 2021, state and local authorities in the USA vaccinated millions of people weekly against coronavirus disease 2019 (COVID-19).[1]. Eligibility progressed in stages per state and local policy. But most jurisdictions allowed everyone age 16 and older to be vaccinated.[10, 11, 12, 13, 14, 15]. On January 1, 2021, 5.5 million people had received at least one dose of a COVID-19 vaccine. That number increased to 30.3 million by February 1, 57.0 million by March 1, 111.1 million by April 1, and 153.7 million by May 1.[16] Growth plateaued in May. Over 206.6 million US residents were at least partially vaccinated by September 1; nearly half of them received their first dose in March or April. Eligibility expansion enabled rapid increases during these months
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of urban health : bulletin of the New York Academy of Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.